Represcription of Low-Dose Acetylsalicylic Acid After Discontinuation in Patients Receiving Treatment for Secondary Cardiovascular Disease Prevention in the UK

Aug-14

AUTHORS : Dr Luis A. Garcia Rodríguez, Spanish Centre for Pharmacoepidemiologic Research (CEIFE), Almirante 28, 28004 Madrid, Spain – Email: lagarcia@ceife.es – Profile: http://www.ceife.es/quienes-somos.html

JOURNAL : American Journal of Cardiovascular Drugs

REFERENCE: 14(4):319-26

DOI : 10.1007/s40256-014-0079-y

Represcription of Low-Dose Acetylsalicylic Acid After Discontinuation in Patients Receiving Treatment for Secondary Cardiovascular Disease Prevention in the UK

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study